Benzinga | Feb 25, 2021 08:16AM EST

Raymond James Maintains Strong Buy on CareDx, Lowers Price Target to $98

Raymond James analyst Andrew Cooper maintains CareDx (NASDAQ:CDNA) with a Strong Buy and lowers the price target from $101 to $98.